Porcine Parvoviruses 2-8

LEVELS: Highly unlikely; No human illness; Already in the herd; No validated assay; Negligible; Negligible; Little; Available, or not needed


Register id	`porcine_parvoviruses_2_8`
Type	virus
Scientific name	Porcine Parvoviruses 2-8
Evidence	1 document(s)
Assigned	2026-09-04, against criteria version `093366e352a2`

Overview

This entry groups seven newer porcine parvoviruses, PPV2 through PPV8, together with porcine bufavirus. They are a genetically miscellaneous set — the members span four different genera and PPV5 is not even classified to genus — held together by the fact that nothing much is known about any of them, and they are kept separate from PPV1, the well-characterised cause of reproductive failure. They are detected independently of PPV1, are most prevalent in growing- finishing pigs and least in pigs under nine weeks, and PPV2 is the one found most often. Several were first identified in pigs in the United States. The reference chapter's summary is that no disease has been unequivocally attributed to any of them. Working on them is difficult: detection relies on PCR because they are hard to grow in cell culture, and virus-specific reagents such as monoclonal antibodies are not widely available. There are no commercial vaccines against any of them and none is warranted on present evidence. There is no evidence that any porcine parvovirus is infectious for people.

C1 Zoonotic potential

Likelihood of transmission from pigs to humans

Highly unlikely: Human infection with the agent has never been reported, or has been reported but is not attributed to pig or pork exposure

How this level was decided

Level 1. The chapter's public health statement is written about PPVs as a class, not about PPV1 alone, so it covers this entry directly rather than by inference. NOTE THE ONE MEMBER WHOSE NAME INVITES A MISREADING and should be handled carefully in any brief: PPV3 is also called "PARV4-like virus", and human parvovirus 4 is a real human agent. The resemblance is phylogenetic, the chapter draws no epidemiological link, and nothing here suggests pigs are a source of it.

C2 Zoonotic impact

Severity of human illness caused by the agent

No human illness: Agent does not cause illness in people

How this level was decided

Level 1, following C1. Under C2 as rescoped, level 1 means pigs are not a source of human illness with this agent.

C3 Herd introduction risk

Effort required to keep the agent out of the herd

Already in the herd: Present in most herds, or carried by pigs themselves, so there is no introduction event to prevent

CONFIRMED by Eric. The assignment reached this level from the evidence, and he has reviewed and ratified it.

Confirmed by Eric. CONFIRMED. "c3l1, likely already in herds and no excludable"

Basis. THE ENTRY IS A GROUP OF EIGHT -- PPV2 through PPV8 plus porcine bufavirus, set by your 2026-08-18 ruling ("one group with 2-8 plus Porcine bufavirus") and following DOS Table 34.1. PPV1 is a separate register entry and is not scored here. The members span four genera and PPV5 is unclassified even at genus level. ch34 34.1, the chapter's own summary of what is known about them: "PPVs 2-8 MAY BE DETECTED EVEN IN THE ABSENCE OF PPV1. Current work shows the HIGHEST PREVALENCE IN GROWING-FINISHING PIGS and the lowest in pigs <9 weeks of age, with PPV2 the most frequently detected. THE ROLE OF THESE VIRUSES IN SWINE HEALTH HAS NOT BEEN DEFINED. THAT IS, NO CAUSAL ASSOCIATION WITH CLINICAL SIGNS HAS BEEN ESTABLISHED. Furthermore, THE PREVALENCE OF THESE VIRUSES IN CLINICALLY HEALTHY ANIMALS RAISES THE POSSIBILITY THAT THEY ARE COMMENSALS." 34.11: "numerous new PPVs have been reported in descriptive papers and even TAXONOMICALLY CLASSIFIED BASED SOLELY ON SEQUENCE DATA (NO INFECTIOUS VIRUS HAS BEEN DETECTED). SO FAR, NO DISEASE HAS BEEN UNEQUIVOCALLY ATTRIBUTED TO ANY OF THESE PPV VIRUSES. THE PROBABILITY OF FINDING VIRUS SEQUENCES IN PIGS INCREASES WITH THE AGE OF THE ANIMALS, AS EXPECTED FOR NONPATHOGENIC VIRUSES." And: "Although PPVs 2-8 are COMMONLY DETECTED in pigs, their clinical significance and their BASIC EPIDEMIOLOGY, INCLUDING TRANSMISSION ROUTES, PATHOGENESIS, CLINICAL SIGNS, AND LESIONS, HAVE NOT BEEN ESTABLISHED." On distribution, 34.11 tracks each member across continents: PPV2 in Myanmar, China, Hungary, THE UNITED STATES, Germany, Thailand, Japan, South Korea and Poland; PPV3 in Hong Kong, Romania, Germany, THE UNITED STATES, China, Poland and Congo; PPV4 "INITIALLY DETECTED FROM PIGS IN THE UNITED STATES" then China, Hungary, Romania and Poland; PPV5 "FIRST IDENTIFIED IN PIGS IN THE UNITED STATES", then China and Poland; PPV6 in China, THE UNITED STATES and Poland; PPV7 in THE UNITED STATES, China, Poland, South Korea and Colombia.

How this level was decided

INFERRED. Level 1 -- already in the herd. The chapter never gives a herd-level prevalence figure the way it does for PPV1, so this is not a stated answer; what it gives instead is a distribution list in which five of the eight members were first identified in or are routinely detected in US pigs, a prevalence that rises with age as commensal flora does, and the possibility raised by the authors that these are commensals. There is no introduction event to prevent. NOTE THE GAP AND WHY IT DOES NOT CHANGE THE ANSWER: the chapter says outright that the transmission routes have not been established, so nobody can say what WOULD exclude these viruses. That would matter if the question were how to keep them out of a clean herd; it does not arise, because the folder describes no clean herd to protect. The chapter's own control advice is the level 1 answer in different words: "THERE IS NO NEED TO ESTABLISH VIRUS-SPECIFIC MEASURES, BESIDES THE APPLICATION OF HIGH BIOSECURITY AND MANAGEMENT STANDARDS."

C4 Detection difficulty

Difficulty of recognizing and confirming infection

No validated assay: No pathogen-specific test of known reliability exists anywhere, and identification depends on sequencing or on primers that have not been critically evaluated

How this level was decided

Level 4, and both halves of the label are met at once. Nothing would ever prompt a clinician to look for these -- there are no clinical signs and no lesions attributed to any of them, so they are not suspected, they are found. And the assay position is the level 4 label in terms: no validated pathogen-specific test, no antibody assay at all, no monoclonals, isolation difficult or never achieved, and identification resting on sequence. THIS IS THE C4 REWORDING OF 2026-08-29 APPLIED AS INTENDED. The axis is whether a VALIDATED assay exists, not whether a published primer set exists -- and the correction made that day was precisely that the pass "had been reading a published primer set as a validated assay". PCR protocols exist for these viruses; nothing in the folder says their accuracy has been established. Scored level with porcine norovirus, sapovirus, astrovirus and Bungowannah virus, the worked examples here, and the resemblance is close: agents known from sequencing, with no serology and no established clinical picture.

C5 Production cost

Financial impact on the infected farm's cost of production

Negligible: No measurable effect on cost of production

CONFIRMED by Eric. The assignment reached this level from the evidence, and he has reviewed and ratified it.

Confirmed by Eric. CONFIRMED. "c5l1, at this time we have little evidence these are any more than 'agents looking for a disease'"

How this level was decided

INFERRED, AND FLAGGED, BECAUSE THIS IS THE CELL THE WHOLE ENTRY TURNS ON and you have ruled both ways on cells of this shape. LEVEL 1 IS SCORED -- negligible, no measurable effect on cost of production. WHY THIS IS AN EXAMINED NEGATIVE RATHER THAN A SILENCE, which is the test that decides it: the chapter does not merely fail to report disease, it makes a positive argument from data that there is none. Prevalence is HIGHEST IN GROWING-FINISHING PIGS and LOWEST IN THE YOUNGEST, and the authors name what that gradient means -- "the probability of finding virus sequences in pigs increases with the age of the animals, AS EXPECTED FOR NONPATHOGENIC VIRUSES". Detection is common in CLINICALLY HEALTHY animals across a dozen countries and fifteen years, and the authors draw the commensal conclusion themselves. That is the same structure you accepted on Saint Valerien virus: "diagnosticians and researchers have looked at the viral biome of thousands of pigs at this point, with and without disease and there is no evidence this agent is associated with significant clinical disease." THE ARGUMENT FOR A NULL, AND IT IS SERIOUS: your PCV4 ruling of 2026-09-03 and your pasivirus ruling of 2026-08-30 both refused a level for an agent whose disease-causing potential was unknown, and the chapter here says in terms that the role of these viruses in swine health HAS NOT BEEN DEFINED. If you read "not defined" as not-yet-known rather than as looked-for-and-not-found, this cell is null and C7 and C8 go with it, and the entry leaves the export. THE DIFFERENCE I AM RELYING ON is the age gradient: PCV4 had no such finding, and this is a positive observation pointing away from pathogenicity rather than an absence of observations.

C6 Market impact

Duration of material disruption to pork and pig markets

Negligible: Little or no material disruption to supply or demand when disease occurs on one or more farms

CONFIRMED by Eric. The assignment reached this level from the evidence, and he has reviewed and ratified it.

Confirmed by Eric. CONFIRMED. "c6l1, no evidence that they have or will have any effect on markets"

How this level was decided

INFERRED. Level 1, and this is a scoreable case under the standing note SCORING/market_impact rather than a void: these are not exotic agents with no US history. Two of the eight were first described in American pigs and four more are routinely reported here, over roughly fifteen years, with no market move of any kind. The absence is an observation.

C7 Treatment potential

Potential for treatment to improve outcomes

Little: Effective pathogen-directed treatment is available and works, or animals recover acceptably without it

CONFIRMED by Eric. The assignment reached this level from the evidence, and he has reviewed and ratified it.

Confirmed by Eric. CONFIRMED. "c7l1, little or no clinical disease associated with agent so little need for treatment"

Basis. THE ENTRY IS A GROUP OF EIGHT -- PPV2 through PPV8 plus porcine bufavirus, set by your 2026-08-18 ruling ("one group with 2-8 plus Porcine bufavirus") and following DOS Table 34.1. PPV1 is a separate register entry and is not scored here. The members span four genera and PPV5 is unclassified even at genus level. ch34 34.1, the chapter's own summary of what is known about them: "PPVs 2-8 MAY BE DETECTED EVEN IN THE ABSENCE OF PPV1. Current work shows the HIGHEST PREVALENCE IN GROWING-FINISHING PIGS and the lowest in pigs <9 weeks of age, with PPV2 the most frequently detected. THE ROLE OF THESE VIRUSES IN SWINE HEALTH HAS NOT BEEN DEFINED. THAT IS, NO CAUSAL ASSOCIATION WITH CLINICAL SIGNS HAS BEEN ESTABLISHED. Furthermore, THE PREVALENCE OF THESE VIRUSES IN CLINICALLY HEALTHY ANIMALS RAISES THE POSSIBILITY THAT THEY ARE COMMENSALS." 34.11: "numerous new PPVs have been reported in descriptive papers and even TAXONOMICALLY CLASSIFIED BASED SOLELY ON SEQUENCE DATA (NO INFECTIOUS VIRUS HAS BEEN DETECTED). SO FAR, NO DISEASE HAS BEEN UNEQUIVOCALLY ATTRIBUTED TO ANY OF THESE PPV VIRUSES. THE PROBABILITY OF FINDING VIRUS SEQUENCES IN PIGS INCREASES WITH THE AGE OF THE ANIMALS, AS EXPECTED FOR NONPATHOGENIC VIRUSES." And: "Although PPVs 2-8 are COMMONLY DETECTED in pigs, their clinical significance and their BASIC EPIDEMIOLOGY, INCLUDING TRANSMISSION ROUTES, PATHOGENESIS, CLINICAL SIGNS, AND LESIONS, HAVE NOT BEEN ESTABLISHED." No treatment for any of these viruses is described anywhere in the chapter, and none is proposed. 34.11: "There is, therefore, NO NEED TO ESTABLISH VIRUS-SPECIFIC MEASURES, besides the application of high biosecurity and management standards."

How this level was decided

INFERRED. Level 1, and it MOVES WITH C5 -- if you null that cell, null this one too. The ground is the second clause of level 1, that animals recover acceptably without treatment, and here the stronger form of it: there is no illness on record to recover from. NOT SCORED LEVEL 1 ON THE GROUND THAT NOBODY TREATS VIRAL DISEASE, which your 2026-09-02 rule forbids and which would be the wrong reason even though it reaches the same answer. THE ARGUMENT FOR LEVEL 3 fails on the criterion's own words: level 3 asks whether outcomes WOULD MEANINGFULLY IMPROVE if a treatment existed, and no outcome has ever been attributed to these viruses that could improve.

C8 Vaccine availability

Availability of effective vaccines or bacterins

Available, or not needed: Effective vaccines are widely available in the US or secured for national outbreak response, or the disease does not clinically or economically justify vaccinating

CONFIRMED by Eric. The assignment reached this level from the evidence, and he has reviewed and ratified it.

Confirmed by Eric. CONFIRMED. "c8l1, little or no clinical disease associated with agent so little need for vaccine"

How this level was decided

INFERRED. Level 1 on the "not needed" clause, by the FIRST route in the standing note SCORING/vaccine_availability -- low clinical significance -- and IT MOVES WITH C5. THE PCV4 RULE IS THE THING TO WATCH HERE and I have applied it consciously rather than around it: asserting a vaccine is not needed is still a claim about the disease, and it cannot be made for an agent whose disease-causing potential is unknown. What makes the claim available here is the same evidence that carries C5 -- the age gradient, the healthy-pig prevalence across a dozen countries, and the authors' own commensal conclusion. THE CHAPTER ALSO MAKES THE CLAIM ITSELF, which PCV4's did not: no need to establish virus-specific measures. IF YOU READ C5 AS A NULL, THIS CELL IS A NULL TOO, because the reason for level 1 here is entirely the reason for level 1 there.

Levels and evidence are generated from data/assignments/porcine_parvoviruses_2_8.yml; the overview is authored in data/overviews/porcine_parvoviruses_2_8.md. Do not hand-edit this page — corrections go in data/assignments/CORRECTIONS.yml.

Quoted material marked Basis is from Zimmerman JJ, Karriker LA, Ramirez A, Schwartz KJ, Stevenson GW, Zhang J, eds. Diseases of Swine, 12th edition. Hoboken: Wiley Blackwell, 2025 — except where another source is named in the quotation itself.

Keys	Action
`?`	Open this help
`n`	Next page
`p`	Previous page
`s`	Search